Here you will find a summary of OSI Pharmaceuticals Inc.'s latest financial information.
| Latest 10-Q | Date Filed | Format | Size | |
|---|---|---|---|---|
| Form 10-Q | Nov 6, 2009 |
|
979.1 KB | |
| Latest Annual Report and 10-K | Date Filed | Format | Size | |
| 2008 Annual Report |
|
2.6 MB | ||
| Form 10-K | Feb 24, 2010 |
|
2.1 MB | |
| Latest Proxy Statement | Date Filed | Format | Size | |
| Proxy Statement (DFAN14A) | Mar 5, 2010 |
|
35.0 KB | |
| Proxy Statement (DFAN14A) | Mar 2, 2010 |
|
43.1 KB | |
| Proxy Statement (DFAN14A) | Mar 2, 2010 |
|
116.6 KB | |
| Proxy Statement (DFAN14A) | Mar 2, 2010 |
|
33.5 KB | |
| Proxy Statement (DFAN14A) | Mar 1, 2010 |
|
103.7 KB | |
| Stock Quote | |
|---|---|
| OSIP (Common Stock) | |
| Exchange | NASDAQ |
| Price | $57.20 |
| Change (%) | 0.55 (0.95%) |
| Volume | 1,621,200 |
| As of 03/11/10 4:00 PM ET Minimum 20 minute delay |
|